The goal of this observational study is to follow all patients implanted with extravascular implantable cardioverter-defibrillators (EV-ICDs) in Belgium throughout the lifetime of the devices. The main goal of the study is to keep track of: * all parameters of the device * complications * arrhythmia detection and therapy delivery * clinical endpoints (quality of life, cardiac and infectious events) Participants who underwent or will undergo an EV-ICD implantation as part of their regular medical care will be asked if data can be collected from their medical record. No additional tasks are required for the study.
See this in plain English?
AI-rewrites the medical criteria so a patient or caregiver can understand them. Always confirm with the trial site.
Number of delivered therapies (ATP and shocks)
Timeframe: Lifetime of the device (up to 15 years)
Proportion of delivered therapies that were appropriate
Timeframe: Lifetime of the device (up to 15 years)
Proportion of delivered therapies that were successful
Timeframe: Lifetime of the device (up to 15 years)
Tracking procedural and device-related complications
Timeframe: Lifetime of the device (up to 15 years)